혈관 실링 기기 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Vessel Sealing Devices Market was valued at USD 3 billion in 2024 and is expected to witness a strong growth trajectory with a 6% CAGR from 2025 to 2034. This robust expansion is largely driven by the rising demand for minimally invasive surgeries, fueled by their benefits, such as faster recovery times, reduced complications, and shorter hospital stays.

As medical advancements continue to evolve, vessel sealing devices are becoming integral to modern surgical procedures, particularly due to their ability to enhance precision and reduce the risk of bleeding. Furthermore, the increasing prevalence of chronic diseases, including cancer and cardiovascular conditions, is contributing significantly to the growth of the market. More patients are opting for procedures that offer reduced trauma and quicker recovery, which in turn is boosting the adoption of vessel sealing technologies. These devices are now a cornerstone of surgical advancements, as they streamline complex procedures, making them safer and more efficient for both patients and healthcare providers.

The market is divided into three key segments: instruments, generators, and accessories, with the instruments category taking the lead. This segment alone generated USD 1.5 billion in revenue in 2024, highlighting its dominance in the sector. Vessel sealing instruments are used extensively across a wide range of surgical specialties, including general surgery, laparoscopic surgery, and robotic-assisted procedures. Their role is pivotal in surgeries such as gynecological procedures, colorectal surgeries, and cancer treatments, where precision and effective sealing of blood vessels is critical for patient safety. The growth of this segment is supported by technological innovations that include ergonomic designs, enhanced articulation, and more efficient sealing mechanisms. These innovations result in better control during surgery, improved outcomes, and reduced surgeon fatigue, ultimately transforming surgical practices across the globe.

In terms of applications, the laparoscopic surgery segment holds the largest share, generating USD 1.9 billion in 2024. Laparoscopic surgery is favored for its minimally invasive nature, providing patients with smaller incisions, reduced risk of complications, and quicker recovery times. As laparoscopic procedures become more prevalent, the demand for vessel sealing devices designed specifically for these surgeries continues to rise. These devices are not only crucial for laparoscopic procedures but also for other specialties such as gynecology, oncology, and colorectal surgeries, where efficient vessel sealing is vital for achieving optimal outcomes.

North America accounted for USD 1.3 billion of the global market in 2024, and it is expected to grow at a CAGR of 5.4% through 2034. This growth is driven by the region's well-established healthcare infrastructure, widespread access to advanced medical technologies, and the increasing number of surgeries related to chronic conditions like cancer and cardiovascular diseases. North America continues to lead the world in minimally invasive surgical procedures, supported by substantial investments in healthcare and surgical technology advancements. Additionally, the presence of major market players in the region fuels innovation, helping to meet the growing demand for cutting-edge vessel sealing devices in surgical practices.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for minimally invasive surgery
    • 3.2.1.2 Technological advancements in vessel sealing devices
    • 3.2.1.3 Rising prevalence of chronic diseases
    • 3.2.1.4 Increasing awareness regarding benefits offered by vessel sealing devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of vessel sealing devices
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2024
• 3.5 Regulatory landscape
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn, Units)

• 5.1 Key trends
• 5.2 Instruments
• 5.3 Generators
• 5.4 Accessories

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Bipolar
• 6.3 Ultrasonic
• 6.4 Monopolar
• 6.5 Hybrid

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Laparoscopic surgery
• 7.3 General surgery

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Specialty clinics
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 B. Braun
• 10.2 Bolder Surgical, LLC
• 10.3 BOWA Medical
• 10.4 CONMED Corporation
• 10.5 Erbe Elektromedizin GmbH
• 10.6 Intuitive Surgical
• 10.7 Johnson & Johnson
• 10.8 KLS Martin Group
• 10.9 Medtronic plc
• 10.10 Micromed
• 10.11 Olympus Corporation
• 10.12 OmniGuide Holdings, Inc.